In a meeting punctuated by conflict and confusion, the independent vaccine advisers to the US Centers for Disease Control and Prevention on Thursday again delayed a vote that could dramatically change hepatitis B vaccination practice in the United States.

A federal vaccine advisory committee is expected to discuss whether newborns should still get the hepatitis B vaccine, the first shot found to prevent cancer.

“We are going to continue to recommend it because it saves lives,” he said.